Background: In vivo transit dosimetry using an electronic portal imaging device (EPID-IVTD) is an important tool for verifying the accuracy of radiation therapy treatments. Despite its potential, the implementation of EPID-IVTD in breast intensity modulated radiation therapy (IMRT) treatments has not yet been standardized, limiting its clinical adoption. A standardized EPID-IVTD method could enhance treatment accuracy and improve patient safety in routine clinical practice. Purpose: This study aims to develop a method for EPID-IVTD for whole breast IMRT treatment. Methods: Gamma passing rates (GPRs) analysis was the basis of the work conducted on a dataset of 50 patients. The first phase of the work focused on the identification of the reference fraction. In the second phase a method for performing EPID-IVTD was implemented. Lower-tolerance and -action limits (l-TL and l-AL), as introduced by AAPM TG 218, were employed to determine the reference fraction and used as alert and alarm thresholds, respectively, in EPID-IVTD monitoring. Results: The first treatment fraction demonstrated the best dosimetric agreement with the theoretical plan and was therefore used as the reference in the second phase of the study. EPID-IVTD results showed that 75% of the GPRs ranged from 97.5% to 99.9%, 93.83% were above the l-TL, 4.31% fell between l-TL and l-AL, and 1.86% were below l-AL. Conclusions: A method for the implementation of an effective EPID-IVTD in whole breast IMRT treatment was developed and is now routinely applied at our center, enabling efficient monitoring in clinical practice.

In vivo transit dosimetry methodology for whole breast intensity modulated radiation therapy

D'Anna A.;Girlando A.;Stella G.;Marino C.
2025-01-01

Abstract

Background: In vivo transit dosimetry using an electronic portal imaging device (EPID-IVTD) is an important tool for verifying the accuracy of radiation therapy treatments. Despite its potential, the implementation of EPID-IVTD in breast intensity modulated radiation therapy (IMRT) treatments has not yet been standardized, limiting its clinical adoption. A standardized EPID-IVTD method could enhance treatment accuracy and improve patient safety in routine clinical practice. Purpose: This study aims to develop a method for EPID-IVTD for whole breast IMRT treatment. Methods: Gamma passing rates (GPRs) analysis was the basis of the work conducted on a dataset of 50 patients. The first phase of the work focused on the identification of the reference fraction. In the second phase a method for performing EPID-IVTD was implemented. Lower-tolerance and -action limits (l-TL and l-AL), as introduced by AAPM TG 218, were employed to determine the reference fraction and used as alert and alarm thresholds, respectively, in EPID-IVTD monitoring. Results: The first treatment fraction demonstrated the best dosimetric agreement with the theoretical plan and was therefore used as the reference in the second phase of the study. EPID-IVTD results showed that 75% of the GPRs ranged from 97.5% to 99.9%, 93.83% were above the l-TL, 4.31% fell between l-TL and l-AL, and 1.86% were below l-AL. Conclusions: A method for the implementation of an effective EPID-IVTD in whole breast IMRT treatment was developed and is now routinely applied at our center, enabling efficient monitoring in clinical practice.
2025
EPID
gamma passing rate
in vivo transit dosimetry
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/20.500.11769/667769
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 0
  • ???jsp.display-item.citation.isi??? 0
social impact